Business Description
Qianjiang Yongan Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000LZ9
Share Class Description:
SZSE:002365: Class ACompare
Compare
Traded in other countries / regions
002365.China IPO Date
2010-03-05Description
Qianjiang Yongan Pharmaceutical Co Ltd is a China-based company principally involved in the manufacturing of taurine products. The company sells its products in China and other international countries.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 44.01 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 5.06 | |||||
| Interest Coverage | 16.43 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.98 | |||||
| Beneish M-Score | -2.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -6.7 | |||||
| 3-Year EBITDA Growth Rate | -17.3 | |||||
| 3-Year FCF Growth Rate | -1.2 | |||||
| 3-Year Book Growth Rate | 4.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.5 | |||||
| 9-Day RSI | 32.93 | |||||
| 14-Day RSI | 39.87 | |||||
| 6-1 Month Momentum % | 13.89 | |||||
| 12-1 Month Momentum % | -14.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.47 | |||||
| Quick Ratio | 5.03 | |||||
| Cash Ratio | 4.22 | |||||
| Days Inventory | 46.72 | |||||
| Days Sales Outstanding | 75.48 | |||||
| Days Payable | 79.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.24 | |||||
| Dividend Payout Ratio | 0.69 | |||||
| 3-Year Dividend Growth Rate | -12.6 | |||||
| Forward Dividend Yield % | 1.24 | |||||
| 5-Year Yield-on-Cost % | 1.24 | |||||
| Shareholder Yield % | 1.22 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 19.41 | |||||
| Operating Margin % | 1.09 | |||||
| Net Margin % | 0.4 | |||||
| FCF Margin % | -2.14 | |||||
| ROE % | 0.16 | |||||
| ROA % | 0.13 | |||||
| ROIC % | -2.18 | |||||
| ROC (Joel Greenblatt) % | 0.39 | |||||
| ROCE % | 0.19 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 740.91 | |||||
| PE Ratio without NRI | 56.21 | |||||
| Shiller PE Ratio | 23.97 | |||||
| PS Ratio | 3.08 | |||||
| PB Ratio | 1.2 | |||||
| Price-to-Tangible-Book | 1.26 | |||||
| Price-to-Operating-Cash-Flow | 19.99 | |||||
| EV-to-EBIT | 361.92 | |||||
| EV-to-EBITDA | 361.92 | |||||
| EV-to-Revenue | 1.81 | |||||
| EV-to-FCF | -103.89 | |||||
| Price-to-Projected-FCF | 0.92 | |||||
| Price-to-Median-PS-Value | 1.1 | |||||
| Price-to-Graham-Number | 1.76 | |||||
| Price-to-Net-Current-Asset-Value | 2.78 | |||||
| Price-to-Net-Cash | 3.98 | |||||
| Earnings Yield (Greenblatt) % | 0.28 | |||||
| FCF Yield % | -0.7 | |||||
| Forward Rate of Return (Yacktman) % | -41.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Qianjiang Yongan Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 788.787 | ||
| EPS (TTM) (Â¥) | 0.011 | ||
| Beta | 0.73 | ||
| Volatility % | 35.73 | ||
| 14-Day RSI | 39.87 | ||
| 14-Day ATR (Â¥) | 0.276717 | ||
| 20-Day SMA (Â¥) | 8.67 | ||
| 12-1 Month Momentum % | -14.55 | ||
| 52-Week Range (Â¥) | 5.45 - 10.19 | ||
| Shares Outstanding (Mil) | 294.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Qianjiang Yongan Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Qianjiang Yongan Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Qianjiang Yongan Pharmaceutical Co Ltd Frequently Asked Questions
What is Qianjiang Yongan Pharmaceutical Co Ltd(SZSE:002365)'s stock price today?
The current price of SZSE:002365 is ¥8.10. The 52 week high of SZSE:002365 is ¥10.19 and 52 week low is ¥5.45.
When is next earnings date of Qianjiang Yongan Pharmaceutical Co Ltd(SZSE:002365)?
The next earnings date of Qianjiang Yongan Pharmaceutical Co Ltd(SZSE:002365) is .
Does Qianjiang Yongan Pharmaceutical Co Ltd(SZSE:002365) pay dividends? If so, how much?
The Dividend Yield %  of Qianjiang Yongan Pharmaceutical Co Ltd(SZSE:002365) is 1.24% (As of Today), Highest Dividend Payout Ratio of Qianjiang Yongan Pharmaceutical Co Ltd(SZSE:002365) was 0.69. The lowest was 0.09. And the median was 0.31. The  Forward Dividend Yield % of Qianjiang Yongan Pharmaceutical Co Ltd(SZSE:002365) is 1.24%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers